| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 11.190 | 19.192 | 14.025 | 20.988 | 18.366 | 20.488 | 20.506 | 24.622 | 18.655 |
| Total Income - EUR | 6.697 | 15.868 | 21.867 | 14.737 | 20.988 | 18.366 | 20.488 | 20.506 | 24.622 | 18.906 |
| Total Expenses - EUR | 293.203 | 6.768 | 15.845 | 7.963 | 8.191 | 8.490 | 9.296 | 10.177 | 16.143 | 16.719 |
| Gross Profit/Loss - EUR | -286.506 | 9.101 | 6.022 | 6.773 | 12.797 | 9.876 | 11.192 | 10.329 | 8.478 | 2.187 |
| Net Profit/Loss - EUR | -286.506 | 8.751 | 5.446 | 6.331 | 12.167 | 9.364 | 10.578 | 9.819 | 8.232 | 1.998 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - C&P Sipp - F. Motamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75.050 | 72.085 | 68.906 | 73.147 | 69.631 | 66.252 | 62.768 | 60.943 | 58.744 | 122.731 |
| Current Assets | 19 | 10.960 | 2.119 | 12.690 | 19.687 | 22.842 | 30.868 | 237.981 | 32.201 | 33.529 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 510 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 2.517 | 0 | 0 | 0 | 0 | 2.212 | 0 |
| Cash | 19 | 10.960 | 2.119 | 10.173 | 19.687 | 22.842 | 30.357 | 237.981 | 29.989 | 33.529 |
| Shareholders Funds | -314.899 | -302.936 | -292.363 | -273.237 | -255.778 | -241.565 | -225.630 | -216.511 | -207.623 | -138.146 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 389.968 | 385.981 | 363.388 | 359.074 | 345.097 | 330.658 | 319.266 | 515.435 | 298.568 | 294.406 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - C&P Sipp - F. Motamed Srl